Supernus Pharmaceuticals
SUPN
#4507
Rank
$2.46 B
Marketcap
$42.38
Share price
0.47%
Change (1 day)
-11.63%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Cash on Hand

Cash on Hand as of June 2026 : $0.37 Billion USD

According to Supernus Pharmaceuticals 's latest financial reports the company has $0.37 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$0.30 B-31.95%
2024-12-31$0.45 B77.97%
2023-12-31$0.25 B-44.75%
2022-12-31$0.46 B35.81%
2021-12-31$0.33 B-19.61%
2020-12-31$0.42 B21.74%
2019-12-31$0.34 B-2.51%
2018-12-31$0.35 B154.23%
2017-12-31$0.14 B55.39%
2016-12-31$90.12 M44.91%
2015-12-31$62.19 M-16.34%
2014-12-31$74.33 M-9.56%
2013-12-31$82.19 M-7.14%
2012-12-31$88.5 M82.33%
2011-12-31$48.54 M48.43%
2010-12-31$32.7 M-50.84%
2009-12-31$66.52 M10.18%
2008-12-31$60.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
$20.75 B 5,479.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$7.29 B 1,860.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$8.95 B 2,305.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.06 B 2,874.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
$2.66 B 615.54%๐Ÿ‡บ๐Ÿ‡ธ USA